<DOC>
	<DOCNO>NCT00717470</DOCNO>
	<brief_summary>To compare well new formulation Tacrolimus® use daily , combination drug help prevent rejection new kidney transplantation compare twice daily dose Tacrolimus</brief_summary>
	<brief_title>A Study Kidney Transplant Subjects Investigate Optimal Suppression Immunity Help Prevent Kidney Rejection</brief_title>
	<detailed_description />
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Basiliximab</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>End stage kidney disease suitable candidate primary renal transplantation retransplantation ( unless graft lose rejection within 12 month ) Receiving kidney transplant cadaveric living ( non HLA identical ) donor compatible ABO blood type Female subject childbearing potential must negative serum pregnancy test enrollment must agree maintain effective birth control study Receiving previously receive organ transplant kidney Cold ischemia time donor kidney &gt; 30 hour Receiving graft nonheartbeating donor Maastricht category 3 ( withdrawn support await cardiac arrest ) Significant liver disease , define continuously elevate SGPT/ALT and/or SGOT/AST and/or total bilirubin level ≥ 2 time upper value normal range investigational site receive graft hepatitis C B positive donor Requiring initial sequential parallel therapy immunosuppressive antibody preparation ( ) Requiring ongoing dose systemic immunosuppressive drug prior transplantation . Significant , uncontrolled concomitant infection and/or severe diarrhea , vomit , active upper gastrointestinal tract malabsorption active peptic ulcer Pregnant woman breastfeed mother Subject donor know HIV positive Known allergy intolerance tacrolimus , macrolide antibiotic , corticosteroid , basiliximab mycophenolate mofetil product excipients Diagnosis newonset malignancy prior transplantation , exception basocellular squamous cell carcinoma skin treat successfully Currently participate another clinical trial , and/or take investigational drug within 28 day prior enrollment Any form substance abuse , psychiatric disorder condition , opinion investigator , may complicate communication investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Kidney</keyword>
	<keyword>Transplant</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Advagraf</keyword>
	<keyword>Prograf</keyword>
	<keyword>FK506</keyword>
</DOC>